IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel, Germany, and Canada. It offers cannabis flowers and strain specific cannabis extracts under the IMC brand; and dried flower, pre-rolls, and pressed hash offerings under the WAGNERS and Highland Grow brands. The company serves medical patients and adult-use recreational consumers. IM Cannabis Corp. is headquartered in Tel Aviv-Yafo, Israel.
According to IM Cannabis Corp.'s latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.39. At the end of 2022 the company had a P/B ratio of 2.51.
Year | P/B ratio |
---|---|
2023 | 2.39 |
2022 | 2.51 |
2021 | 0.58 |
2020 | 207.47 |
2019 | 0.17 |
2018 | -17.57 |
2017 | 0.01 |
2016 | 0.01 |
2015 | 0.01 |
2014 | 0.18 |
2013 | 0.07 |
2012 | 1.23 |
2011 | 0.85 |
2010 | 2.41 |
2009 | 1.82 |
2008 | 2.63 |
2007 | 3.82 |
2006 | 5.18 |
2005 | 2.72 |
2004 | 1.94 |
2003 | 4.65 |
2002 | 0.00 |
2001 | 0.00 |
2000 | 0.00 |
1999 | 0.00 |
1998 | 0.00 |
1997 | 0.00 |
1996 | 0.00 |